{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:23:58Z","timestamp":1745987038916,"version":"3.40.4"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":6641,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:p>One of the biggest challenges in medicine is the area of therapeutics, wherein the physician attempts to match the needs of the individual patient with a specific agent from the pharmacopeia, at the dose that might be best suited to treat the individual's problem. A great deal of the art of medicine is involved in this \u201cmatching process,\u201d in which the scientific aspects of diagnosis and therapy meet with the physician's knowledge of clinical pharmacology. The abbreviated case histories of six patients who came to the author with specific questions regarding therapy of their hypertension and renal impairment illustrate the fact that one of any number of therapies might have reduced blood pressure in these patients, but in each, there was a specific reason to attempt a single approach first. If physicians could better understand and extrapolate the results of clinical research to the treatment of specific patients, choice of therapy might become more successful.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1995.tb04751.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T19:04:26Z","timestamp":1362769466000},"page":"98-102","source":"Crossref","is-referenced-by-count":0,"title":["An Individualized Approach to the Hypertensive Patient with Renal Disease: Six Illustrative Case Studies"],"prefix":"10.1002","volume":"35","author":[{"given":"William J.","family":"Elliott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archinte.1993.00410020010002","article-title":"The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure","volume":"153","author":"Gifford RW","year":"1993","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archinte.1988.00380050029006","article-title":"The Fourth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure","volume":"147","author":"Chobanian AM","year":"1988","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"265","author":"SHEP Cooperative Study Group","year":"1991","journal-title":"JAMA"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1985.tb07117.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208203270808"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"II\u20107","DOI":"10.1161\/01.HYP.11.3_Pt_2.II4","article-title":"Antagonism of antihypertensive drug therapy by non\u2010steroidal anti\u2010inflammatory drugs","volume":"11","author":"Oates JA","year":"1988","journal-title":"Hypertension"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_1_9_2","unstructured":"USA Today November 11 1993 Section D page 1 column a."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-9-707"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(87)80191-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470040085027"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92619-Q"},{"key":"e_1_2_1_14_2","first-page":"344","article-title":"Cost\u2010effectiveness in the detection renovascular hypertension","volume":"3","author":"England WJ","year":"1988","journal-title":"J Int Med"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197912063012307"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1001\/jama.1992.03490230083033","article-title":"Newer tests for the diagnosis of renovascular disease","volume":"268","author":"Davidson RA","year":"1992","journal-title":"JAMA"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-10-845"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archinte.1993.00410060061010","article-title":"Comparison of two noninvasive screening tests for renovascular hypertension","volume":"153","author":"Elliott WJ","year":"1993","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.157.1.2048539"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.1987.00370050016004","article-title":"Report of the Working Group on the Detection, Evaluation, and Treatment of Renovascular Hypertension","volume":"147","author":"Working Group on Renovascular Hypertension","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.13.2.163"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.1987.03390040114028","article-title":"Trends in surgical revascularization for renal artery disease: Ten years' experience","volume":"257","author":"Novick AC","year":"1987","journal-title":"JAMA"},{"key":"e_1_2_1_23_2","first-page":"94A","article-title":"Discontinuation rates for ACE\u2010inhibitors and calcium antagonists in a tertiary hypertension clinic (abstract)","volume":"6","author":"Elliott WJ","year":"1993","journal-title":"Am J Hypertens"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90630-H"},{"key":"e_1_2_1_25_2","first-page":"451","article-title":"Effect of sulindac on angiotensin converting enzyme inhibitor\u2010induced cough: randomised placebo\u2010controlled double\u2010blind cross\u2010over study","volume":"3","author":"Gilchrist NL","year":"1989","journal-title":"J Hum Hypertension"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(25)12743-2","article-title":"The effect of sulindac on the abnormal cough reflex associated with dry cough","volume":"255","author":"Ewan JR","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199308020-00002"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90449-W"},{"key":"e_1_2_1_29_2","first-page":"670","article-title":"Effects of nifedipine and indomethacin on cough induced by angiotensin converting enzyme inhibitors: a double\u2010blind, randomized, crossover study","volume":"19","author":"Fogar R","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1093\/ajh\/4.1.46S","article-title":"Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex","volume":"4","author":"Ogihara T","year":"1991","journal-title":"Am J Hypertension"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.93"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1995.tb04751.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1995.tb04751.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:39:12Z","timestamp":1745969952000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1995.tb04751.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1002\/j.1552-4604.1995.tb04751.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1995.tb04751.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"type":"print","value":"0091-2700"},{"type":"electronic","value":"1552-4604"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}